CalCog’s established returns for redistribution procedure aids sponsor in keeping pivotal trial on time and in budget. A clinical-stage pharmaceutical company with a novel therapeutic for a common yet debilitating condition discovered that product distribution for its...
A novel approach to wallet card design & manufacturing helps an innovator avoid costly Phase III study delays. A global biopharmaceutical company sponsored a Phase III, randomized, double-blind study to gain approval for extending its commercially available...
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.